{"generic":"Rotavirus Vaccine, Live","drugs":["Rotarix","Rotavirus Vaccine, Live"],"mono":{"0":{"id":"924780-s-0","title":"Generic Names","mono":"Rotavirus Vaccine, Live"},"1":{"id":"924780-s-1","title":"Dosing and Indications","sub":{"1":{"id":"924780-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>Rotashield(R), a tetravalent human-rhesus reassortant vaccine, was withdrawn from the market on October 14, 1999 because of a temporal association between the use of Rotashield(R) vaccine and the development of intussusception<\/li><li><b>Viral gastroenteritis due to Rotavirus; Prophylaxis:<\/b> As of May 14, 2010, the US Food and Drug Administration (FDA) has recommended that clinicians resume use of the Rotarix(R) vaccine despite the presence of porcine circovirus type-1 DNA (PCV1) in the vaccine, as there is no evidence of a safety risk<\/li><li><b>Viral gastroenteritis due to Rotavirus; Prophylaxis:<\/b> Rotarix(R), 1 mL ORALLY at 6 weeks of age, second dose after an interval of 4 weeks and prior to 24 weeks of age (manufacturer dosing)  OR 2 dose series given at 2 and 4 months of age (guideline dosing)<\/li><\/ul>"},"3":{"id":"924780-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Rotashield(R), a tetravalent human-rhesus reassortant vaccine, was withdrawn from the market on October 14, 1999 because of a temporal association between the use of Rotashield(R) vaccine and the development of intussusception [1]<\/li><li>Viral gastroenteritis due to Rotavirus; Prophylaxis<\/li><\/ul>"}}},"3":{"id":"924780-s-3","title":"Contraindications\/Warnings","sub":[{"id":"924780-s-3-9","title":"Contraindications","mono":"<ul><li>severe allergic reaction (eg, anaphylaxis) after a previous dose or to a vaccine component (CDC); history of hypersensitivity to any component of the vaccine (manufacturer)<\/li><li>intussusception, history; fatal cases of intussusception have been reported<\/li><li>Severe Combined Immunodeficiency Disease (SCID), history<\/li><li>uncorrected congenital malformation of the gastrointestinal tract (eg, Meckel's diverticulum), history<\/li><\/ul>"},{"id":"924780-s-3-10","title":"Precautions","mono":"<ul><li>acute illness with or without fever, moderate or severe; defer vaccination unless the benefit of protection outweighs the risk of an adverse reaction<\/li><li>bladder exstrophy<\/li><li>close contact to non-vaccinated individuals and\/or individuals with immunodeficiencies; theoretical risk of transmission due to shedding of virus in stool<\/li><li>diarrhea or vomiting, acute; delay administration of vaccine<\/li><li>gastrointestinal disease, chronic<\/li><li>immunocompetence, altered, other than severe combined immunodeficiency disease (SCID)<\/li><li>latex sensitivity; tip cap and oral applicator contain dry natural latex rubber<\/li><li>spina bifida<\/li><li>report any adverse events to GlaxoSmithKline at 1-888-825-5249 or through the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967 or www.vaers.hhs.gov<\/li><\/ul>"},{"id":"924780-s-3-11","title":"Pregnancy Category","mono":"<ul><li>C (FDA)<\/li><li>B2 (AUS)<\/li><\/ul>"},{"id":"924780-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk is minimal.<br\/>"}]},"4":{"id":"924780-s-4","title":"Drug Interactions","sub":[{"id":"924780-s-4-13","title":"Contraindicated","mono":"<ul><li>Aclarubicin (established)<\/li><li>Aldesleukin (established)<\/li><li>Altretamine (established)<\/li><li>Amonafide (established)<\/li><li>Amsacrine (established)<\/li><li>Asparaginase (established)<\/li><li>Azacitidine (established)<\/li><li>Betamethasone (established)<\/li><li>Bleomycin (established)<\/li><li>Broxuridine (established)<\/li><li>Busulfan (established)<\/li><li>Capecitabine (established)<\/li><li>Carboplatin (established)<\/li><li>Carmustine (established)<\/li><li>Chlorambucil (established)<\/li><li>Cisplatin (established)<\/li><li>Cladribine (established)<\/li><li>Corticotropin (established)<\/li><li>Cortisone (established)<\/li><li>Cosyntropin (established)<\/li><li>Cyclophosphamide (established)<\/li><li>Cytarabine (established)<\/li><li>Cytarabine Liposome (established)<\/li><li>Dacarbazine (established)<\/li><li>Dactinomycin (established)<\/li><li>Daunorubicin (established)<\/li><li>Daunorubicin Citrate Liposome (established)<\/li><li>Decitabine (established)<\/li><li>Deflazacort (established)<\/li><li>Dexamethasone (established)<\/li><li>Docetaxel (established)<\/li><li>Doxifluridine (established)<\/li><li>Doxorubicin (established)<\/li><li>Doxorubicin Hydrochloride Liposome (established)<\/li><li>Edatrexate (established)<\/li><li>Eflornithine (established)<\/li><li>Epirubicin (established)<\/li><li>Estramustine (established)<\/li><li>Etoposide (established)<\/li><li>Floxuridine (established)<\/li><li>Fludarabine (established)<\/li><li>Fludrocortisone (established)<\/li><li>Fluocortolone (established)<\/li><li>Fluorouracil (established)<\/li><li>Fotemustine (established)<\/li><li>Gallium Nitrate (established)<\/li><li>Gemcitabine (established)<\/li><li>Hydrocortisone (established)<\/li><li>Hydroxyurea (established)<\/li><li>Idarubicin (established)<\/li><li>Ifosfamide (established)<\/li><li>Interferon Alfa (established)<\/li><li>Interferon Alfacon-1 (established)<\/li><li>Interferon Beta (established)<\/li><li>Interferon Beta-1a (established)<\/li><li>Interferon Beta-1b (established)<\/li><li>Interferon Gamma (established)<\/li><li>Irinotecan (established)<\/li><li>Lomustine (established)<\/li><li>Mechlorethamine (established)<\/li><li>Melphalan (established)<\/li><li>Mercaptopurine (established)<\/li><li>Methotrexate (established)<\/li><li>Methylprednisolone (established)<\/li><li>Mitolactol (established)<\/li><li>Mitomycin (established)<\/li><li>Mitotane (established)<\/li><li>Mitoxantrone (established)<\/li><li>Oxaliplatin (established)<\/li><li>Paclitaxel (established)<\/li><li>Paclitaxel Protein-Bound (established)<\/li><li>Paramethasone (established)<\/li><li>Pegaspargase (established)<\/li><li>Pentostatin (established)<\/li><li>Pipobroman (established)<\/li><li>Pirarubicin (established)<\/li><li>Plicamycin (established)<\/li><li>Prednisolone (established)<\/li><li>Prednisone (established)<\/li><li>Procarbazine (established)<\/li><li>Raltitrexed (established)<\/li><li>Rituximab (established)<\/li><li>Streptozocin (established)<\/li><li>Teceleukin (established)<\/li><li>Tegafur (established)<\/li><li>Teniposide (established)<\/li><li>Thioguanine (established)<\/li><li>Thiotepa (established)<\/li><li>Topotecan (established)<\/li><li>Treosulfan (established)<\/li><li>Triamcinolone (established)<\/li><li>Trimetrexate (established)<\/li><li>Trofosfamide (established)<\/li><li>Uracil Mustard (established)<\/li><li>Vinblastine (established)<\/li><li>Vincristine (established)<\/li><li>Vincristine Sulfate Liposome (established)<\/li><li>Vindesine (established)<\/li><li>Vinorelbine (established)<\/li><\/ul>"},{"id":"924780-s-4-14","title":"Major","mono":"<ul><li>Adalimumab (theoretical)<\/li><li>Alemtuzumab (established)<\/li><li>Azathioprine (established)<\/li><li>Certolizumab Pegol (theoretical)<\/li><li>Cyclosporine (theoretical)<\/li><li>Etanercept (established)<\/li><li>Everolimus (theoretical)<\/li><li>Fingolimod (theoretical)<\/li><li>Golimumab (theoretical)<\/li><li>Immune Globulin (probable)<\/li><li>Infliximab (theoretical)<\/li><li>Mycophenolic Acid (theoretical)<\/li><li>Rilonacept (theoretical)<\/li><li>Secukinumab (theoretical)<\/li><li>Siltuximab (theoretical)<\/li><li>Sirolimus (probable)<\/li><li>Tacrolimus (theoretical)<\/li><li>Temsirolimus (theoretical)<\/li><li>Teriflunomide (theoretical)<\/li><li>Trabectedin (theoretical)<\/li><li>Ustekinumab (theoretical)<\/li><\/ul>"},{"id":"924780-s-4-15","title":"Moderate","mono":"<ul><li>Abatacept (probable)<\/li><li>Cytomegalovirus Immune Globulin, Human (probable)<\/li><li>Hepatitis B Immune Globulin (probable)<\/li><li>Leflunomide (established)<\/li><li>Rabies Immune Globulin (probable)<\/li><li>Respiratory Syncytial Virus Immune Globulin, Human (probable)<\/li><li>Tetanus Immune Globulin (probable)<\/li><li>Vaccinia Immune Globulin, Human (probable)<\/li><li>Varicella-Zoster Immune Globulin (probable)<\/li><\/ul>"}]},"5":{"id":"924780-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Gastrointestinal:<\/b>Vomiting (8% to 13%)<\/li><li><b>Psychiatric:<\/b>Irritability (11.4% to 52%)<\/li><li><b>Other:<\/b>Patient shedding virus<\/li><\/ul><b>Serious<\/b><ul><li><b>Gastrointestinal:<\/b>Diarrhea (3% to 4%), Intussusception of intestine<\/li><li><b>Respiratory:<\/b>Pneumonia<\/li><li><b>Other:<\/b>Death, Kawasaki disease<\/li><\/ul>"},"6":{"id":"924780-s-6","title":"Drug Name Info","sub":{"0":{"id":"924780-s-6-17","title":"US Trade Names","mono":"Rotarix<br\/>"},"2":{"id":"924780-s-6-19","title":"Class","mono":"Vaccine<br\/>"},"3":{"id":"924780-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"924780-s-7","title":"Mechanism Of Action","mono":"The rotavirus vaccine, live (Rotarix(R) is a live attenuated vaccine derived from the human 89-12 strain belonging to G1P[8] type, and contains at least 10(6) median Cell Culture Infective Dose of live, attenuated rotavirus. Although the exact mechanism of live rotavirus vaccine is unclear, it contains a live, attenuated human rotavirus that replicates in the small intestine and induces immunity against gastroenteritis.<br\/>"},"8":{"id":"924780-s-8","title":"Pharmacokinetics","sub":[{"id":"924780-s-8-23","title":"Absorption","mono":"Effect of food: none <br\/>"}]},"9":{"id":"924780-s-9","title":"Administration","mono":"<b>Oral<\/b><br\/><ul><li>for oral use only<\/li><li>reconstitute only with supplied diluent and administer within 24 hours of reconstitution<\/li><li>administer on inside of cheek while infant in reclining position<\/li><li>if infant regurgitates, spits out, or vomits during or after administration, it is not recommended to readminister the dose; remaining recommended doses should be given at the appropriate intervals<\/li><li>do mix with other solutions or vaccines<\/li><\/ul>"},"13":{"id":"924780-s-13","title":"Clinical Teaching","mono":"<ul><li>Drug may cause fussiness\/irritability, cough\/runny nose, fever, loss of appetite, and vomiting.<\/li><li>Advise parent\/caregiver to call healthcare professional if second dose is missed, as drug should be given on a fixed schedule.<\/li><\/ul>"}}}